GALNS antibody (AA 20-269)
Quick Overview for GALNS antibody (AA 20-269) (ABIN1886170)
Target
See all GALNS AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 20-269
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 20 and 269 of GALNS
-
-
-
-
Application Notes
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.500
Immunofluorescence: 1.100-1.200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- GALNS (Galactosamine (N-Acetyl)-6-Sulfate Sulfatase (GALNS))
-
Alternative Name
- GALNS
-
Background
-
This gene encodes N-acetylgalactosamine-6-sulfatase which is a lysosomal exohydrolase required for the degradation of the glycosaminoglycans, keratan sulfate, and chondroitin 6-sulfate.Sequence alterations including point, missense and nonsense mutations, as well as those that affect splicing, result in a deficiency of this enzyme.Deficiencies of this enzyme lead to Morquio A syndrome, a lysosomal storage disorder.[provided by RefSeq]
-
Molecular Weight
- 58 kDa
-
Gene ID
- 2588
-
NCBI Accession
- NP_000503, NM_000512
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-